Therefore, in line with the results of these recent studies, it is believed that the adiponectin/leptin ratio may be an important inflammatory marker that can be used to investigate comorbidities in patients with severe obesity and MetS before and after bariatric surgery. This evidence concerns the gene LEP and Obesity.